Cargando…
LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
Autor principal: | Zweytick, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859424/ https://www.ncbi.nlm.nih.gov/pubmed/31798060 http://dx.doi.org/10.15698/cst2019.11.202 |
Ejemplares similares
-
LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent
por: Camilio, Ketil André, et al.
Publicado: (2014) -
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021) -
The oncolytic peptide LTX-315 triggers immunogenic cell death
por: Zhou, H, et al.
Publicado: (2016) -
LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
por: Liao, Hsin-Wei, et al.
Publicado: (2019) -
Copper – a novel stimulator of autophagy
por: Zischka, Hans, et al.
Publicado: (2020)